Kineta Immuno-Oncology, LLC logo

Kineta Immuno-Oncology, LLC

Kineta, Immuno-oncology is a privately held biotech company focused on developing disruptive technologies that shift the paradigm in cancer treatment by turning cold tumors hot.

Kineta, Immuno-oncology is a subsidary of Kineta, Inc. and is based on the novel technology that was originally discovered through the innate immune screening platform developed by Kineta, Inc.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.kinetaimmuno-oncology.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
219 Terry Ave N Ste 300,WA 98109-5230
Seattle
United States
Email
Contact Number
+1 206 378 0400

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

Kineta Immuno-Oncology is developing small molecule drugs targeting RIG-I pathway, a disruptive technology focused on immune stimulation to turn cold tumors hot.